As of Jul 22
| +0.04 / +0.12%|
The 5 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 45.00, with a high estimate of 47.00 and a low estimate of 33.00. The median estimate represents a +39.15% increase from the last price of 32.34.
The current consensus among 6 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.